Literature DB >> 13689019

The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum.

R W BURGESS, R S BRAY.   

Abstract

A number of studies have been carried out on the effect of several of the 8-aminoquinolines on gametogony and sporogony of Laverania falciparum, but only very limited work has so far been done on the effect of single doses of primaquine. The authors have sought to repair this omission with a study of 12 subjects showing gametocytes of L. falciparum who were treated with a single dose of 15 mg, 30 mg or 45 mg of primaquine base, according to age. Batches of Anopheles gambiae were fed on these gametocyte carriers before and up to 7 days after treatment.It was found that a single dose of primaquine clears the blood of crescents in 4-8 days. In 5 out of 8 cases no gland infections were seen in A. gambiae fed on the first day after treatment; in 3 cases, however, sporozoites were found. After the first day following treatment no sporozoite infection of A. gambiae occurred in the 3 cases in which gland dissections were made. Feeding oöcyst-infected A. gambiae on a subject having received primaquine 3 and 4 hours before the feed had no effect on the development of the parasite.Following treatment, gametogony was apparently normal but oökinetes did not penetrate the gut wall, showed staining differences after 24 hours, and appeared to be dead after 48 hours.

Entities:  

Keywords:  ANTIMALARIALS/pharmacology; PLASMODIUM FALCIPARUM/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 13689019      PMCID: PMC2555915     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases.

Authors:  G M JEFFERY; M D YOUNG; D E EYLES
Journal:  Am J Hyg       Date:  1956-07

2.  [Comparative gametocidal effect of primaquine and plasmoquine in experimental research with animals].

Authors:  L MUDROW-REICHENOW
Journal:  Z Tropenmed Parasitol       Date:  1953-03

3.  Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum.

Authors:  M J MACKERRAS; Q N ERCOLE
Journal:  Trans R Soc Trop Med Hyg       Date:  1949-03       Impact factor: 2.184

4.  The development of pyrimethamine resistance by Plasmodium falciparum.

Authors:  R W BURGESS; M D YOUNG
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

5.  Effect of pyrimethamine upon sporogony and pre-erythrocytic schizogony of Laverania falciparum.

Authors:  R S BRAY; R W BURGESS; R M FOX; M J MILLER
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

  5 in total
  25 in total

1.  Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine.

Authors:  Julia Penna-Coutinho; Maria Jesús Almela; Celia Miguel-Blanco; Esperanza Herreros; Paula M Sá; Núbia Boechat; Antoniana Ursine Krettli
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Pharmacology of 8-aminoquinolines.

Authors:  R S Grewal
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

Review 4.  Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.

Authors:  Rashad Abdul-Ghani; John C Beier
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

5.  Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs.

Authors:  Michael J Delves; Andrea Ruecker; Ursula Straschil; Jöel Lelièvre; Sara Marques; María José López-Barragán; Esperanza Herreros; Robert E Sinden
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

6.  Reinventing primaquine for endemic malaria.

Authors:  John Kevin Baird
Journal:  Expert Opin Emerg Drugs       Date:  2012-09-21       Impact factor: 4.191

7.  Determinants of MDA impact and designing MDAs towards malaria elimination.

Authors:  Bo Gao; Sompob Saralamba; Yoel Lubell; Lisa J White; Arjen M Dondorp; Ricardo Aguas
Journal:  Elife       Date:  2020-04-15       Impact factor: 8.140

8.  Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.

Authors:  Naman K Shah; Allan Schapira; Jonathan J Juliano; Bina Srivastava; Pia D M MacDonald; Charles Poole; Anup Anvikar; Steven R Meshnick; Neena Valecha; Neelima Mishra
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

9.  Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum.

Authors:  K H Rieckmann; J V McNamara; H Frischer; T A Stockert; P E Carson; R D Powell
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

10.  Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.

Authors:  Frank Smithuis; Moe Kyaw Kyaw; Ohn Phe; Thein Win; Pyay Phyo Aung; Aung Pyay Phyo Oo; Arkar Linn Naing; Mya Yee Nyo; Naing Zaw Htun Myint; Mallika Imwong; Elizabeth Ashley; Sue J Lee; Nicholas J White
Journal:  Lancet Infect Dis       Date:  2010-09-09       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.